PubRank

T N Schumacher

Author PubWeight™ 55.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001 6.19
2 Empty MHC class I molecules come out in the cold. Nature 1990 5.53
3 CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000 3.84
4 CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med 1999 2.77
5 TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 1993 2.43
6 Immunotherapy through TCR gene transfer. Nat Immunol 2001 2.41
7 Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus. Cell 1993 1.96
8 Peptide translocation by variants of the transporter associated with antigen processing. Science 1993 1.71
9 Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med 2001 1.62
10 Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J Exp Med 1999 1.58
11 Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. Eur J Immunol 1991 1.51
12 Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001 1.40
13 Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci U S A 1997 1.40
14 Systemic T cell expansion during localized viral infection. Eur J Immunol 1999 1.37
15 Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses. Eur J Immunol 1992 1.30
16 Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses. J Immunol 2001 1.27
17 Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity 2000 1.22
18 In situ detection of virus- and tumor-specific T-cell immunity. Nat Med 2000 1.14
19 Assembly and intracellular transport of major histocompatibility complex molecules. Curr Opin Cell Biol 1991 0.98
20 Tracing and characterization of the low-avidity self-specific T cell repertoire. Eur J Immunol 2000 0.97
21 Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells. Cell Immunol 1999 0.97
22 A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Eur J Immunol 1992 0.93
23 Low-avidity self-specific T cells display a pronounced expansion defect that can be overcome by altered peptide ligands. J Immunol 2001 0.93
24 Regulatory role of CD19 molecules in B-cell activation and differentiation. Cell Immunol 1989 0.93
25 Changing T cell specificity by retroviral T cell receptor display. Proc Natl Acad Sci U S A 2000 0.91
26 Polymorphisms in pockets of major histocompatibility complex class I molecules influence peptide preference. J Exp Med 1993 0.91
27 Preferred size of peptides that bind to H-2 Kb is sequence dependent. Eur J Immunol 1992 0.90
28 DNA vaccines and intradermal vaccination by DNA tattooing. Curr Top Microbiol Immunol 2012 0.82
29 Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection. J Hepatol 2010 0.82
30 Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif. Leukemia 2010 0.82
31 Repertoire-determining role of peptide in the positive selection of CD8+ T cells. Immunol Rev 1993 0.81
32 Transposon leads to contamination of clinical pDNA vaccine. Vaccine 2013 0.79
33 A soluble, single-chain Kd molecule produced by yeast selects a peptide repertoire indistinguishable from that of cell-surface-associated Kd. Eur J Immunol 1993 0.78
34 Immunology. Accessory to murder. Nature 1999 0.76
35 Circumventing T-cell tolerance to tumour antigens. Biologicals 2002 0.76
36 CMV-specific CD8(pos) T lymphocyte differentiation in latent CMV infection. Transplant Proc 2001 0.76
37 Requirements for induction of activation and proliferation of human B cells analysed with anti-idiotype monoclonal antibodies. Scand J Immunol 1989 0.75
38 Differentiation of CMV-specific CD8(POS) T lymphocytes in primary CMV infection after renal transplantation. Transplant Proc 2001 0.75